Literature DB >> 16399536

Early and late effects of passive epicardial constraint on left ventricular geometry: ellipsoidal re-shaping confirmed by electron-beam computed tomography.

Alexander Lembcke1, Simon Dushe, Pascal M Dohmen, Udo Hoffmann, Brigitte Wegner, Christian Kloeters, Christian N H Enzweiler, Bernd Hamm, Wolfgang F Konertz.   

Abstract

BACKGROUND: Previous studies have shown that passive epicardial constraint using a cardiac support device (CSD) reduces left ventricular (LV) size. However, specific data describing LV shape and the time course of changes in LV geometry are still incomplete. Thus, the aim of this study was-using 3-dimensional data sets obtained by computed tomography (CT)-to test the hypothesis that the CSD not only alters LV size but also LV shape, and that short-term post-operative changes in LV geometry are maintained during long-term follow-up.
METHODS: Ten patients with non-ischemic dilated cardiomyopathy underwent electron-beam CT examination before and again at 2.6 +/- 0.5 and 32.4 +/- 8.7 months after CSD implantation. At end-diastole and end-systole LV volumes, the length-to-width diameter ratio and a sphericity index were determined and ejection fraction and end-systolic meridional and circumferential wall stress were calculated.
RESULTS: Implantation of the CSD led to a significant reduction in LV size, a more ellipsoidal LV shape and a subsequent decrease of LV wall stress post-operatively (p < 0.05 for each), but no substantial changes were found between short- and long-term follow-up (p > 0.05 each). Mean pre-operative and early and late post-operative end-diastolic values were 310.4 +/- 87.8, 235.5 +/- 102.0 and 229.4 +/- 103.1 ml for volume; 1.27 +/- 0.20, 1.37 +/- 0.20 and 1.38 +/- 0.20 for diameter ratio; and 0.78 +/- 0.22, 0.67 +/- 0.26 and 0.65 +/- 0.23 for sphericity index. A similar pattern was observed for end-systolic values. Ejection fraction was 23.4 +/- 6.2%, 32.9 +/- 11.6% and 34.4 +/- 14.9%. End-systolic meridional and circumferential wall stress was 182.2 +/- 45.6, 128.2 +/- 52.6, 130.6 +/- 56.7 kdyn/cm(2) and 411.5 +/- 94.0, 297.4 +/- 108.4 and 302.8 +/- 117.5 kdyn/cm(2), respectively.
CONCLUSIONS: Three-dimensional data obtained by CT demonstrate that passive cardiac constraint leads not only to a size reduction but also to an ellipsoidal re-shaping. Our data indicate that these effects are primarily a short-term consequence of the CSD implantation but are maintained during long-term follow-up.

Entities:  

Mesh:

Year:  2005        PMID: 16399536     DOI: 10.1016/j.healun.2005.02.025

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  7 in total

Review 1.  Device therapy for remodeling in congestive heart failure.

Authors:  Edward A Carraway; Barry K Rayburn
Journal:  Curr Heart Fail Rep       Date:  2007-03

Review 2.  Diastolic ventricular support with cardiac support devices: an alternative approach to prevent adverse ventricular remodeling.

Authors:  Pavan Atluri; Michael A Acker
Journal:  Heart Fail Rev       Date:  2013-01       Impact factor: 4.214

3.  Mechanical circulatory support-results, developments and trends.

Authors:  Thomas Krabatsch; Martin Schweiger; Alexander Stepanenko; Marian Kukucka; Juliane Vierecke; Hans B Lehmkuhl; Michael Huebler; Ewald Hennig; Evgenij Potapov; Roland Hetzer
Journal:  J Cardiovasc Transl Res       Date:  2011-03-11       Impact factor: 4.132

Review 4.  New insights into the role of thyroid hormone in cardiac remodeling: time to reconsider?

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2011-01       Impact factor: 4.214

5.  Material properties of CorCap passive cardiac support device.

Authors:  Sam Chitsaz; Jonathan F Wenk; Liang Ge; Andrew Wisneski; Aart Mookhoek; Mark B Ratcliffe; Julius M Guccione; Elaine E Tseng
Journal:  Ann Thorac Surg       Date:  2012-09-13       Impact factor: 4.330

Review 6.  Rebuilding the post-infarcted myocardium by activating 'physiologic' hypertrophic signaling pathways: the thyroid hormone paradigm.

Authors:  Constantinos Pantos; Iordanis Mourouzis; Dennis V Cokkinos
Journal:  Heart Fail Rev       Date:  2008-09-05       Impact factor: 4.214

7.  Biventricular finite element modeling of the Acorn CorCap Cardiac Support Device on a failing heart.

Authors:  Jonathan F Wenk; Liang Ge; Zhihong Zhang; Dimitri Mojsejenko; D Dean Potter; Elaine E Tseng; Julius M Guccione; Mark B Ratcliffe
Journal:  Ann Thorac Surg       Date:  2013-05-02       Impact factor: 4.330

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.